サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1073512

がん生検の世界市場：業界分析、規模、シェア、成長、動向、予測（2022年～2028年）

Global Cancer Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日: | 発行: Value Market Research | ページ情報: 英文 169 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
がん生検の世界市場：業界分析、規模、シェア、成長、動向、予測（2022年～2028年）
出版日: 2022年04月01日
発行: Value Market Research
ページ情報: 英文 169 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん生検の市場規模は、今後数年間に著しく成長すると予想されています。

当レポートでは、世界のがん生検市場について調査分析し、業界分析、市場規模、市場シェア、市場動向、市場促進・抑制要因、COVID-19の影響分析、セグメント別・地域別の市場分析、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 がん生検：業界分析

  • 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界の動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
  • 潜在的バイヤーのリスト
  • マーケティングチャネル

第5章 COVID-19アウトブレイクの影響分析

  • COVID-19アウトブレイクの影響分析
  • COVID-19の影響分析：生産、輸入、輸出および需要別
  • 市場：COVID-19前 vs. COVID-19後
  • COVID-19エピデミックの推定影響
  • COVID-19：ミクロおよびマクロ因子分析

第6章 世界のがん生検市場分析：製品別

  • 概要
  • 実績データと予測データ
  • 分析
  • 機器市場
  • 消耗品市場
  • サービス市場

第7章 世界のがん生検市場分析：タイプ別

  • 概要
  • 実績データと予測データ
  • 分析
  • 組織生検（針生検、穿刺吸引生検（FNA）、コア針生検（CNB）、外科生検）市場
  • リキッドバイオプシー市場
  • その他の市場

第8章 世界のがん生検市場分析：用途別

  • 概要
  • 実績データと予測データ
  • 分析
  • 乳がん市場
  • 結腸直腸がん市場
  • 子宮頸がん市場
  • 肺がん市場
  • 前立腺がん市場
  • 皮膚がん市場
  • 血液がん市場
  • 腎臓がん市場
  • 肝臓がん市場
  • 膵臓がん市場
  • 卵巣がん市場

第9章 世界のがん生検市場分析：地域別

  • 地域の見通し
  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 がん生検企業の競合情勢

  • がん生検市場競争
  • パートナーシップ/提携/契約
  • 合併と買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Qiagen NV
  • GRAIL, Inc
  • Illumina, Inc.
  • ANGLE Plc
  • BD(Becton, Dickinson And Company)
  • Myriad Genetics
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Lucence Diagnostics Pte. Ltd.
  • Guardant Health
  • Exact Sciences Corporation
  • Biodesix(Integrated Diagnostics)
  • Freenome Holdings, Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Instruments Market by Geography (USD MN)
  • Kits and Consumables Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
  • Liquid Biopsies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Colorectal Cancer Market by Geography (USD MN)
  • Cervical Cancers Market by Geography (USD MN)
  • Lung Cancers Market by Geography (USD MN)
  • Prostate Cancers Market by Geography (USD MN)
  • Skin Cancers Market by Geography (USD MN)
  • Blood Cancers Market by Geography (USD MN)
  • Kidney Cancers Market by Geography (USD MN)
  • Liver Cancers Market by Geography (USD MN)
  • Pancreatic Cancers Market by Geography (USD MN)
  • Ovarian Cancers Market by Geography (USD MN)
  • Global Cancer Biopsy Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cancer Biopsy Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Biopsy Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Instruments Market by Geography (USD MN)
  • Kits and Consumables Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
  • Liquid Biopsies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Colorectal Cancer Market by Geography (USD MN)
  • Cervical Cancers Market by Geography (USD MN)
  • Lung Cancers Market by Geography (USD MN)
  • Prostate Cancers Market by Geography (USD MN)
  • Skin Cancers Market by Geography (USD MN)
  • Blood Cancers Market by Geography (USD MN)
  • Kidney Cancers Market by Geography (USD MN)
  • Liver Cancers Market by Geography (USD MN)
  • Pancreatic Cancers Market by Geography (USD MN)
  • Ovarian Cancers Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213945

Value Market Research deeply researched the Global Cancer Biopsy Market to foresee a significant growth in the industry over the upcoming years. The global cancer biopsy market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer biopsy market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer biopsy market.

The next sections of the cancer biopsy market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies)

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CANCER BIOPSY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product
    • 3.7.2 By Type
    • 3.7.3 By Application
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Instruments Market by Regions
  • 6.6 Kits and Consumables Market by Regions
  • 6.5 Services Market by Regions

7 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Regions
  • 7.5 Liquid Biopsies Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Breast Cancer Market by Regions
  • 8.5 Colorectal Cancer Market by Regions
  • 8.6 Cervical Cancers Market by Regions
  • 8.7 Lung Cancers Market by Regions
  • 8.8 Prostate Cancers Market by Regions
  • 8.9 Skin Cancers Market by Regions
  • 8.10. Blood Cancers Market by Regions
  • 8.11 Kidney Cancers Market by Regions
  • 8.12 Liver Cancers Market by Regions
  • 8.13 Pancreatic Cancers Market by Regions
  • 8.14 Ovarian Cancers Market by Regions

9 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE CANCER BIOPSY COMPANIES

  • 10.1. Cancer Biopsy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CANCER BIOPSY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Qiagen N.V.
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. GRAIL, Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Illumina, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. ANGLE Plc
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. BD (Becton, Dickinson And Company)
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Myriad Genetics
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Hologic, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Biocept, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Thermo Fisher Scientific, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Danaher
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. F. Hoffmann-La Roche Ltd.
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Lucence Diagnostics Pte. Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financials
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Guardant Health
    • 11.15.1. Company Overview
    • 11.15.2. Financials
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Exact Sciences Corporation
    • 11.16.1. Company Overview
    • 11.16.2. Financials
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Biodesix (Integrated Diagnostics)
    • 11.17.1. Company Overview
    • 11.17.2. Financials
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Freenome Holdings, Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financials
    • 11.18.3. Products
    • 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies